| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 04/13/2004 | US6720183 Cytoplasmic inhibition of gene expression |
| 04/13/2004 | US6720181 Ubiquitin ligases as therapeutic targets |
| 04/13/2004 | US6720174 Stabilizing amino acid mutations are introduced into a homologous protein, or the active site of a phytase is replaced in part or in toto. |
| 04/13/2004 | US6720173 Shares structural similarity with animal kinases, including, but not limited to serine/threonine protein kinases. |
| 04/13/2004 | US6720172 Nucleic acid fragment encoding a sulfite reductase |
| 04/13/2004 | US6720142 Wherein the gene confers a selectable advantage to the host cell; determining whether the mutant resistance gene is likely to evolve through two or more independent mutation events. |
| 04/13/2004 | US6720140 Recombinational cloning using engineered recombination sites |
| 04/13/2004 | US6720014 Culturing escherichia coli; genetic engineering and expression |
| 04/13/2004 | US6719986 Fermented by microorganisms; skin disorders; aging and wrinkle resistance |
| 04/13/2004 | US6719973 Lipopolysaccharide (lps)-binding peptide; septic shock treatment |
| 04/08/2004 | WO2004029577A2 Hemipteran myosin light chain kinase |
| 04/08/2004 | WO2004029271A1 Recombinant microorganism for the production of vitamin b6 |
| 04/08/2004 | WO2004029269A1 Process for producing vitamin c |
| 04/08/2004 | WO2004029261A2 Production of canthaxanthin by phaffia |
| 04/08/2004 | WO2004029257A1 Plants having changed development and a method for making the same |
| 04/08/2004 | WO2004029255A2 Squalene synthase 8sqs9 gen |
| 04/08/2004 | WO2004029253A2 Nucleic acid sequences coding for proteolytic enzymes in the form of specific proteases, corresponding polypeptides and use of the same |
| 04/08/2004 | WO2004029252A2 A gene encoding vitamin b6 phosphate phosphatase and use thereof |
| 04/08/2004 | WO2004029251A1 Fructosylamine oxidase |
| 04/08/2004 | WO2004029250A1 Dna encoding flavin-adenine-dinucleotide-dependent-d-erythronate-4-phosphate-dehydrogenase, pdxr, and microbial production of vitamin b6 |
| 04/08/2004 | WO2004029246A2 Integrase cofactor |
| 04/08/2004 | WO2004029242A1 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same |
| 04/08/2004 | WO2004029239A1 Crystal structure of chorismate synthase and uses thereof |
| 04/08/2004 | WO2004029238A1 Human tissue kallikrein-specific immunoglobulin, immunologic formulation comprising the immunoglobulin and related diagnostic kit for the diagnosis of cerebral ischemia |
| 04/08/2004 | WO2004029237A1 Splice-variants of the human leukotriene a-4 hydrolase |
| 04/08/2004 | WO2004029236A1 Atomic structure of the catalytic domain for use in designing and identifying inhibitors of zap-70 kinase |
| 04/08/2004 | WO2004029235A2 Aldehyde dehydrogenase gene |
| 04/08/2004 | WO2004029234A1 Bhyd gene |
| 04/08/2004 | WO2004029233A2 Mutant recombinases |
| 04/08/2004 | WO2004029232A2 Acc gene |
| 04/08/2004 | WO2004029228A1 Microorganism and process for preparing vitamin b6 |
| 04/08/2004 | WO2004029202A2 Microbial trypsin variants having chymotrypsin activity and nucleic acids encoding same |
| 04/08/2004 | WO2004029193A1 Fermentation methods and compositions |
| 04/08/2004 | WO2004029094A1 Monoclonal antibody specific for human mitochondrial adenylate kinase isozyme 3 |
| 04/08/2004 | WO2004029091A2 FVII OR FVIIa VARIANTS HAVING INCREASED CLOTTING ACTIVITY |
| 04/08/2004 | WO2004029084A2 Lipase inhibitors and uses thereof |
| 04/08/2004 | WO2004028342A2 Endogenous granzyme b in human non-hematopoietic cells |
| 04/08/2004 | WO2004028341A2 Susceptibility gene for human stroke; methods of treatment |
| 04/08/2004 | WO2004028243A2 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 04/08/2004 | WO2004018662A3 Cellulases and hemicellulases and uses thereof |
| 04/08/2004 | WO2004016730A3 Bacteria that can overproduce and secrete proteins |
| 04/08/2004 | WO2004015096A3 Leech extracts for stents |
| 04/08/2004 | WO2004011637A3 Modified adamts4 molecules and method of use thereof |
| 04/08/2004 | WO2004009619A3 Protein complexes of the tip60 transcriptional activator protein |
| 04/08/2004 | WO2004007704A3 Neuronally expressed tryptophane hydroxylase and its use |
| 04/08/2004 | WO2004007512A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/08/2004 | WO2004003139A3 Modified shine-dalgarno sequences and methods of use thereof |
| 04/08/2004 | WO2003106619A3 Multifunctional polypeptides |
| 04/08/2004 | WO2003101184A3 Carotenoid synthesis |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003089633A3 Crystallised thermostable glycosyl hydrolase and use thereof for modifying structurally related enzymes |
| 04/08/2004 | WO2003087386A3 Methods for producing sulphurous fine chemicals by fermentation using meth-coding coryneform bacteria |
| 04/08/2004 | WO2003080646A3 Modified plasminogen activator inhibitor type-1 and methods based thereon |
| 04/08/2004 | WO2003078597A3 Tissue engineering |
| 04/08/2004 | WO2003076610A3 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
| 04/08/2004 | WO2003070925A3 Identification of 3-ketosteroid 9-alfa-hydroxylase genes and microorganisms blocked in 3-ketosteroid 9-alfa-hydroxylase activity |
| 04/08/2004 | WO2003053158A9 Malleable protein matrix and uses thereof |
| 04/08/2004 | WO2003033646A8 Compositions and methods for the modulation of viral maturation |
| 04/08/2004 | WO2003018790A8 Enzyme with the removal activities of the plaques, dna sequence encoding said enzyme, the expressing host cell and methods for producing and purifying said enzyme |
| 04/08/2004 | WO2003012102A3 Nucleic acids coding for novel hect domain proteins, their diagnostic and therapeutic uses |
| 04/08/2004 | WO2003012030A3 Isoform-selective inhibitors and activators of pde3 cyclic |
| 04/08/2004 | WO2002083854A3 Antibodies to vla-1 |
| 04/08/2004 | WO2002081668A9 Desaturase genes and uses thereof |
| 04/08/2004 | WO2002074992A3 Phosphodiesterase 4d genes related to human stroke |
| 04/08/2004 | WO2002072541A3 Human grk7: new member of the human g-protein-coupled-receptor kinase family |
| 04/08/2004 | WO2001094537A3 Novel polypeptide--human nadh ubiquinone oxidoreductase 21.89 and polynucleotide encoding it |
| 04/08/2004 | WO2001083678A3 A novel polypeptide, homo uridylic acid kinase 13 and polynucleotide encoding said polypeptide |
| 04/08/2004 | WO2001075042A3 A novel polypeptide, atp-dependent human hydrolase serine 9 and the polynucleotide encoding the polypeptide |
| 04/08/2004 | WO2001075034A3 A novel polypeptide, human peroxydase protein 15 and the polynucleotide encoding the polypeptide |
| 04/08/2004 | US20040068768 Comprises meiotic replication protein (MRE11) for use as gene transfer tool in plant transformation; tissue engineering |
| 04/08/2004 | US20040068767 Maize cellulose synthases and uses thereof |
| 04/08/2004 | US20040068766 Transgenic plant expressing starch branching enzyme for use in detergents, textile treatment, food processing and papermaking |
| 04/08/2004 | US20040068765 Plant fatty acid synthases and use in improved methods for production of medium-chain fatty acids |
| 04/08/2004 | US20040067904 Gene therapy for prostate cancer: sensibilization of cells to dna damaging drugs and radiation |
| 04/08/2004 | US20040067882 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/08/2004 | US20040067579 Process for oxidation of steroids and genetically engineered cells used therein |
| 04/08/2004 | US20040067572 Pectate lyases |
| 04/08/2004 | US20040067571 Process for preparing cellulase and protease enzyme complex cud liquor from cattle and buffaloes cud for biodegradation of organic materials cud for biodegredation of organic materials |
| 04/08/2004 | US20040067570 Using cellulase to isolate hydrolases from grains |
| 04/08/2004 | US20040067569 Polypeptides having xyloglucanase activity and nucleic acids encoding same |
| 04/08/2004 | US20040067568 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/08/2004 | US20040067567 Phosphorylated glyoxalase I and its use |
| 04/08/2004 | US20040067566 Process for producing coenzyme q10 |
| 04/08/2004 | US20040067565 Oxofunctionalized hydrocarbons are important synthons e.g. for the synthesis of various pharmaceutically relevant compounds |
| 04/08/2004 | US20040067557 Producing UDP-N- acetylgalactosamine and an N-acetylgalactosamine-containing carbohydrate using a protein having UDP-N-acetylglucosamine 4- epimerase activity; for anticancer treatment |
| 04/08/2004 | US20040067555 Recombinant hosts suitable for simultaneous saccharification and fermentation |
| 04/08/2004 | US20040067522 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 04/08/2004 | US20040067515 Human proteinase molecules |
| 04/08/2004 | US20040067513 84569, a novel human map kinase family member and uses therefor |
| 04/08/2004 | US20040067497 A method for screening a candidate protein for E3 ligase activity; a method of screening a test compound for the ability to regulate the post-translational modification of a target protein by a post- translational modifier polypeptide |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067225 Isolated nucleic acid molecules human glucuronyltransferase proteins, and related products and processes |
| 04/08/2004 | US20040064901 Coloring keratin using enzyme as oxidation catalyst, a sugar surfactant and reducing agent |
| 04/08/2004 | DE10239629A1 Nicht-rekombinate Subunit-Vakzine gegen Streptococcus suis-Infektionen des Schweines Non-recombinant subunit vaccines against Streptococcus suis infection in pigs |
| 04/08/2004 | CA2840692A1 Fvii or fviia variants having increased clotting activity |
| 04/08/2004 | CA2502162A1 Fvii or fviia variants having increased clotting activity |
| 04/08/2004 | CA2500140A1 Crystal structure of chorismate synthase and uses thereof |
| 04/08/2004 | CA2498381A1 Acc gene |
| 04/08/2004 | CA2497840A1 Plants transformed with cdc27a, having changed development |